242 related articles for article (PubMed ID: 1732770)
1. A comparison of nonionic, low-osmolality radiocontrast agents with ionic, high-osmolality agents during cardiac catheterization.
Barrett BJ; Parfrey PS; Vavasour HM; O'Dea F; Kent G; Stone E
N Engl J Med; 1992 Feb; 326(7):431-6. PubMed ID: 1732770
[TBL] [Abstract][Full Text] [Related]
2. Safety and cost effectiveness of high-osmolality as compared with low-osmolality contrast material in patients undergoing cardiac angiography.
Steinberg EP; Moore RD; Powe NR; Gopalan R; Davidoff AJ; Litt M; Graziano S; Brinker JA
N Engl J Med; 1992 Feb; 326(7):425-30. PubMed ID: 1732769
[TBL] [Abstract][Full Text] [Related]
3. Nonionic low-osmolality versus ionic high-osmolality contrast material for intravenous use in patients perceived to be at high risk: randomized trial.
Barrett BJ; Parfrey PS; McDonald JR; Hefferton DM; Reddy ER; McManamon PJ
Radiology; 1992 Apr; 183(1):105-10. PubMed ID: 1549654
[TBL] [Abstract][Full Text] [Related]
4. Decision analysis to assess cost-effectiveness of low-osmolality contrast medium for intravenous urography.
Calvo MV; Pilar del Val M; Mar Alvarez M; Domínguez-Gil A
Am J Hosp Pharm; 1992 Mar; 49(3):577-84. PubMed ID: 1598930
[TBL] [Abstract][Full Text] [Related]
5. Nonionic low-osmolar contrast media have no impact on major adverse cardiac events in patients undergoing coronary stenting with appropriate antiplatelet therapy.
Danzi GB; Capuano C; Sesana M; Predolini S; Baglini R
Catheter Cardiovasc Interv; 2003 Dec; 60(4):477-82. PubMed ID: 14624424
[TBL] [Abstract][Full Text] [Related]
6. The clotting issue: etiologic factors in thromboembolism. I. Chemistry, pharmacology, and toxicity of angiographic contrast agents.
Dawson P
Invest Radiol; 1993 Nov; 28 Suppl 5():S25-30. PubMed ID: 8282499
[TBL] [Abstract][Full Text] [Related]
7. [The effects of contrast media on the cardiac conducting system in coronary angiography].
Kawamori J
Nihon Igaku Hoshasen Gakkai Zasshi; 1989 Nov; 49(11):1372-81. PubMed ID: 2602100
[TBL] [Abstract][Full Text] [Related]
8. The safety and cost-effectiveness of low osmolar contrast media. Can economic analysis determine the real worth of a new technology?
Henry DA; Evans DB; Robertson J
Med J Aust; 1991 Jun; 154(11):766-72. PubMed ID: 1828529
[TBL] [Abstract][Full Text] [Related]
9. Contrast nephrotoxicity: a randomized controlled trial of a nonionic and an ionic radiographic contrast agent.
Schwab SJ; Hlatky MA; Pieper KS; Davidson CJ; Morris KG; Skelton TN; Bashore TM
N Engl J Med; 1989 Jan; 320(3):149-53. PubMed ID: 2643042
[TBL] [Abstract][Full Text] [Related]
10. Adverse reactions to contrast media: factors that determine the cost of treatment.
Powe NR; Moore RD; Steinberg EP
AJR Am J Roentgenol; 1993 Nov; 161(5):1089-95. PubMed ID: 8273616
[TBL] [Abstract][Full Text] [Related]
11. Selective use of low-osmolality contrast agents for i.v. urography and CT: safety and effect on cost.
Hunter TB; Dye J; Duval JF
AJR Am J Roentgenol; 1994 Oct; 163(4):965-8. PubMed ID: 8092044
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of intravascular low-osmolality contrast agents.
Swanson DP; Thrall JH; Shetty PC
Clin Pharm; 1986 Nov; 5(11):877-91. PubMed ID: 3780159
[TBL] [Abstract][Full Text] [Related]
13. A prospective trial of ionic vs nonionic contrast agents in routine clinical practice: comparison of adverse effects.
Wolf GL; Arenson RL; Cross AP
AJR Am J Roentgenol; 1989 May; 152(5):939-44. PubMed ID: 2495706
[TBL] [Abstract][Full Text] [Related]
14. Trends in adverse events after IV administration of contrast media.
Cochran ST; Bomyea K; Sayre JW
AJR Am J Roentgenol; 2001 Jun; 176(6):1385-8. PubMed ID: 11373197
[TBL] [Abstract][Full Text] [Related]
15. [Hemodynamic effects of non-ionic iomeprol 350 and ionic diatrizoate 370 during levocardiography and coronary angiography--double-blind randomized comparison of 2 contrast media].
Lins M; Röhling D; Zahorsky R; Höfig M; Herrmann G; Simon R
Z Kardiol; 1994 Sep; 83(9):626-33. PubMed ID: 7801664
[TBL] [Abstract][Full Text] [Related]
16. A prospective randomised controlled trial to determine the early and late reactions after the use of iopamidol 340 (Niopam) and iomeprol 350 (Iomeron) in cardiac catheterisation.
Vijayalakshmi K; Kunadian B; Wright RA; Hall JA; Stewart MJ; Davies A; Sutton A; de Belder MA
Eur J Radiol; 2007 Feb; 61(2):342-50. PubMed ID: 17101256
[TBL] [Abstract][Full Text] [Related]
17. [Late reactions to a radiologic contrast media (Iopamidol-Bracco). Prospective study].
Bartolucci F; Cecarini M; Gabrielli G; Abbiati R; Barberio M; Busilacchi P
Radiol Med; 2000 Oct; 100(4):273-8. PubMed ID: 11155455
[TBL] [Abstract][Full Text] [Related]
18. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B.
Brown G; Albers JJ; Fisher LD; Schaefer SM; Lin JT; Kaplan C; Zhao XQ; Bisson BD; Fitzpatrick VF; Dodge HT
N Engl J Med; 1990 Nov; 323(19):1289-98. PubMed ID: 2215615
[TBL] [Abstract][Full Text] [Related]
19. A comparison of low- with high-osmolality contrast agents in cardiac angiography. Identification of criteria for selective use.
Matthai WH; Kussmaul WG; Krol J; Goin JE; Schwartz JS; Hirshfeld JW
Circulation; 1994 Jan; 89(1):291-301. PubMed ID: 8281660
[TBL] [Abstract][Full Text] [Related]
20. Nephrotoxicity from contrast material in renal insufficiency: ionic versus nonionic agents.
Harris KG; Smith TP; Cragg AH; Lemke JH
Radiology; 1991 Jun; 179(3):849-52. PubMed ID: 2028004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
